Clin2
NCT06210321Possibly a fitNot yet recruiting

Pharmacogenetic testing at community pharmacy

Pharmacogenetic Testing

This study tests whether giving patients a genetic test before they start the antidepressant escitalopram can help doctors choose a safer and more effective dose. It is for people with unipolar depression, with or without anxiety, who have not taken this medication before.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
270 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are starting treatment with escitalopram for depression (with or without anxiety).
  • You have not taken escitalopram in the past.
  • You do not have another mental health condition like panic disorder.
  • You are able to understand the study and give your consent.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04507555Recruiting
Pharmacist-guided genetic testing to choose antidepressants

This study tests whether doing genetic testing before starting or adjusting antidepressants—guided by a pharmacist—can improve treatment for people with moderate to severe depression. The goal is to help match you with antidepressants more safely and effectively.

Münchenbuchsee, Canton of Bern
NCT07480486Not yet recruiting
Personalized antidepressant selection using genetic testing

This study tests whether using a genetic test can help doctors choose the most effective antidepressant for people with depression. The goal is to improve treatment outcomes and reduce side effects by tailoring the medication to your genetic makeup.

Rabat, Rabat-Salé-Kénitra
NCT06853587Recruiting
Genetic test to help pick antidepressant for teens

This study tests whether using a cheek swab DNA test can help choose a better antidepressant for teenagers with anxiety or depression. The goal is to see if this personalized approach leads to fewer side effects and better results.

Calgary, Alberta
NCT07373470Recruiting
Pharmacist help with depression meds using your DNA

This trial tests whether a pharmacist can use your genetic information to better manage your depression medications. It may help find the right drug or dose for you.

Pittsburgh, Pennsylvania
NCT04623099Recruiting· Phase 4
Personalized escitalopram dosing for anxious teens

This study tests whether a genetics-guided approach to choosing and adjusting escitalopram (an anxiety medicine) can improve safety and effectiveness for anxious teens. It also checks that participants have certain anxiety severity scores and can safely take the study medication.

Cincinnati, Ohio
NCT06929533Recruiting
Genetic testing to guide mental health medication

This study tests if using genetic information can help doctors choose the right mental health medication or dose. It may help find treatments that work better with fewer side effects.

Winnipeg, Manitoba

Hear when a new Pharmacogenetic Testing trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.